• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

A case of breakthrough infection with SARS-CoV-2 Delta derivative and reinfection with Omicron variant in a fully vaccinated health care professional.

作者信息

Pandit Priyanka, Bhatt Puneet, Sahay Rima R, Joshi Yash, Patil Deepak Y, Yadav Pragya D

机构信息

Indian Council of Medical Research-National Institute of Virology, 411021 Pune, India.

Army Hospital Research and Referral, 110010 New Delhi, India.

出版信息

J Infect. 2022 Jul;85(1):e15-e17. doi: 10.1016/j.jinf.2022.04.023. Epub 2022 Apr 18.

DOI:10.1016/j.jinf.2022.04.023
PMID:35447232
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9014656/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/870c/9014656/9f8d4c270836/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/870c/9014656/5002a9f075ee/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/870c/9014656/9f8d4c270836/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/870c/9014656/5002a9f075ee/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/870c/9014656/9f8d4c270836/gr2_lrg.jpg

相似文献

1
A case of breakthrough infection with SARS-CoV-2 Delta derivative and reinfection with Omicron variant in a fully vaccinated health care professional.一名全程接种疫苗的医护人员出现严重急性呼吸综合征冠状病毒2（SARS-CoV-2）德尔塔变异株突破性感染及奥密克戎变异株再次感染的病例。
J Infect. 2022 Jul;85(1):e15-e17. doi: 10.1016/j.jinf.2022.04.023. Epub 2022 Apr 18.
2
Role of previous infection with SARS-CoV-2 in protecting against omicron reinfections and severe complications of COVID-19 compared to pre-omicron variants: a systematic review.奥密克戎变异株与新冠前变异株相比，既往感染 SARS-CoV-2 在预防再感染和 COVID-19 严重并发症方面的作用：系统评价。
BMC Infect Dis. 2023 Jun 26;23(1):432. doi: 10.1186/s12879-023-08328-3.
3
SARS CoV-2 reinfection rate is higher in the Omicron variant than in the Alpha and Delta variants.奥密克戎变异株的 SARS-CoV-2 再感染率高于阿尔法和德尔塔变异株。
Ir J Med Sci. 2023 Apr;192(2):751-756. doi: 10.1007/s11845-022-03060-4. Epub 2022 Jun 17.
4
SARS-CoV-2 immune response and reinfection in vaccinated Maya and mestizo in Southeast of Mexico.墨西哥东南部接种疫苗的玛雅人和梅斯蒂索人的 SARS-CoV-2 免疫反应和再感染。
Salud Publica Mex. 2023 Dec 8;66(1, ene-feb):14-16. doi: 10.21149/15186.
5
Estimated Protection of Prior SARS-CoV-2 Infection Against Reinfection With the Omicron Variant Among Messenger RNA-Vaccinated and Nonvaccinated Individuals in Quebec, Canada.在加拿大魁北克省，mRNA 疫苗接种者和未接种者中，先前感染 SARS-CoV-2 对奥密克戎变异株再感染的估计保护作用。
JAMA Netw Open. 2022 Oct 3;5(10):e2236670. doi: 10.1001/jamanetworkopen.2022.36670.
6
Protection against symptomatic infection with delta (B.1.617.2) and omicron (B.1.1.529) BA.1 and BA.2 SARS-CoV-2 variants after previous infection and vaccination in adolescents in England, August, 2021-March, 2022: a national, observational, test-negative, case-control study.2021 年 8 月至 2022 年 3 月，英国青少年在先前感染和接种疫苗后对 delta（B.1.617.2）和 omicron（B.1.1.529）BA.1 和 BA.2 SARS-CoV-2 变异株的症状性感染的保护作用：一项全国性、观察性、基于检测的病例对照研究。
Lancet Infect Dis. 2023 Apr;23(4):435-444. doi: 10.1016/S1473-3099(22)00729-0. Epub 2022 Nov 24.
7
SARS-CoV-2 vaccine breakthrough reinfection in a health-care worker of Iraq: A case report.伊拉克一名医护人员出现严重急性呼吸综合征冠状病毒2型（SARS-CoV-2）疫苗突破性再感染：病例报告
Hum Vaccin Immunother. 2022 Nov 30;18(5):2055947. doi: 10.1080/21645515.2022.2055947. Epub 2022 Apr 13.
8
Vaccine effectiveness against SARS-CoV-2 reinfection during periods of Alpha, Delta, or Omicron dominance: A Danish nationwide study.疫苗对 Alpha、Delta 或奥密克戎变异株流行期间 SARS-CoV-2 再感染的有效性：一项丹麦全国性研究。
PLoS Med. 2022 Nov 22;19(11):e1004037. doi: 10.1371/journal.pmed.1004037. eCollection 2022 Nov.
9
Prevalence of symptoms, comorbidities, and reinfections in individuals infected with Wild-Type SARS-CoV-2, Delta, or Omicron variants: a comparative study in western Mexico.在墨西哥西部，比较感染野生型 SARS-CoV-2、Delta 或 Omicron 变异株的个体的症状、合并症和再感染的流行情况：一项比较研究。
Front Public Health. 2023 Apr 27;11:1149795. doi: 10.3389/fpubh.2023.1149795. eCollection 2023.
10
Immediate reinfection with Omicron variant after clearance of a previous SARS-CoV-2 infection.先前感染 SARS-CoV-2 清除后即刻再次感染奥密克戎变异株。
J Infect Public Health. 2022 Sep;15(9):983-985. doi: 10.1016/j.jiph.2022.07.013. Epub 2022 Jul 28.

引用本文的文献

1
A mini review of reinfection with the SARS-CoV-2 Omicron variant.严重急性呼吸综合征冠状病毒2型奥密克戎变种再感染的小型综述。
Health Sci Rep. 2024 Apr 10;7(4):e2016. doi: 10.1002/hsr2.2016. eCollection 2024 Apr.
2
Identification of severe acute respiratory syndrome coronavirus 2 breakthrough infections by anti-nucleocapsid antibody among fully vaccinated non-healthcare workers during the transition from the delta to omicron wave.在从德尔塔毒株流行期过渡到奥密克戎毒株流行期期间，通过抗核衣壳抗体在完全接种疫苗的非医护人员中识别严重急性呼吸综合征冠状病毒2突破性感染情况。
Front Med (Lausanne). 2022 Nov 29;9:1019490. doi: 10.3389/fmed.2022.1019490. eCollection 2022.
3

本文引用的文献

1
Reinfection and Breakthrough Infection of SARS-CoV-2: An Emerging Challenge That Is Threatening Our World.新型冠状病毒（SARS-CoV-2）的再感染和突破性感染：一个正在威胁我们世界的新挑战。
Infect Dis Immun. 2021 Nov 3;2(1):29-33. doi: 10.1097/ID9.0000000000000027. eCollection 2022 Jan.
2
Protection against the Omicron Variant from Previous SARS-CoV-2 Infection.既往感染严重急性呼吸综合征冠状病毒2对奥密克戎变异株的防护作用。
N Engl J Med. 2022 Mar 31;386(13):1288-1290. doi: 10.1056/NEJMc2200133. Epub 2022 Feb 9.
3
Disease severity during SARS-COV-2 reinfection: a nationwide study.
Omicron BA.2 lineage predominance in severe acute respiratory syndrome coronavirus 2 positive cases during the third wave in North India.
在印度北部第三波疫情期间，严重急性呼吸综合征冠状病毒2阳性病例中奥密克戎BA.2谱系占主导地位。
Front Med (Lausanne). 2022 Nov 2;9:955930. doi: 10.3389/fmed.2022.955930. eCollection 2022.
SARS-CoV-2 再感染期间的疾病严重程度：一项全国性研究。
J Infect. 2022 Apr;84(4):542-550. doi: 10.1016/j.jinf.2022.01.012. Epub 2022 Jan 25.
4
SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses.严重急性呼吸综合征冠状病毒2型奥密克戎变异株B.1.1.529可导致广泛的中和抗体反应逃逸。
Cell. 2022 Feb 3;185(3):467-484.e15. doi: 10.1016/j.cell.2021.12.046. Epub 2022 Jan 4.
5
A systematic review of Vaccine Breakthrough Infections by SARS-CoV-2 Delta Variant.关于 SARS-CoV-2 德尔塔变异株疫苗突破性感染的系统评价。
Int J Biol Sci. 2022 Jan 1;18(2):889-900. doi: 10.7150/ijbs.68973. eCollection 2022.
6
Variants of concern responsible for SARS-CoV-2 vaccine breakthrough infections from India.引发 SARS-CoV-2 疫苗突破性感染的关注变体来自印度。
J Med Virol. 2022 Apr;94(4):1696-1700. doi: 10.1002/jmv.27461. Epub 2021 Nov 25.
7
Longitudinal clinico-serological analysis of anti-nucleocapsid and anti-receptor binding domain of spike protein antibodies against SARS-CoV-2.对 SARS-CoV-2 的核衣壳蛋白和刺突蛋白受体结合域的抗体进行纵向临床血清学分析。
Int J Infect Dis. 2021 Nov;112:103-110. doi: 10.1016/j.ijid.2021.09.024. Epub 2021 Sep 17.
8
Predominance of delta variant among the COVID-19 vaccinated and unvaccinated individuals, India, May 2021.2021年5月，印度，新冠疫苗接种者与未接种者中德尔塔变异株的优势情况
J Infect. 2022 Jan;84(1):94-118. doi: 10.1016/j.jinf.2021.08.006. Epub 2021 Aug 6.
9
Development of transcribed RNA as positive control for laboratory diagnosis of SARS-CoV-2 in India.转录RNA作为印度SARS-CoV-2实验室诊断阳性对照的开发。
Indian J Med Res. 2020;151(2 & 3):251-254. doi: 10.4103/ijmr.IJMR_671_20.